A Placebo‐controlled Double‐blind Study of Epalrestat (ONO‐2235) in Patients with Diabetic Neuropathy

This publication has 10 references indexed in Scilit:

• Regeneration and Repair of Myelinated Fibers in Sural-Nerve Biopsy Specimens from Patients with Diabetic Neuropathy Treated with Sorbinil
  New England Journal of Medicine, 1988
• Nerve Glucose, Fructose, Sorbitol,myo-Inositol, and Fiber Degeneration and Regeneration in Diabetic Neuropathy
  New England Journal of Medicine, 1988
• Glucose-induced Alterations in Nerve Metabolism: Current Perspective on the Pathogenesis of Diabetic Neuropathy and Future Directions for Research and Therapy
  Diabetes Care, 1985
• Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats
  Diabetologia, 1985
• Prevention of peripheral nerve dysfunction by an aldose reductase inhibitor in streptozotocin-diabetic rats
  Metabolism, 1984
• TREATMENT OF SEVERELY PAINFUL DIABETIC NEUROPATHY WITH AN ALDOSE REDUCTASE INHIBITOR: RELIEF OF PAIN AND IMPROVED SOMATIC AND AUTONOMIC NERVE FUNCTION
  The Lancet, 1983
• Aldose Reductase Inhibition Improves Nerve Conduction Velocity in Diabetic Patients
  New England Journal of Medicine, 1983
• Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus
  Neuroscience Letters, 1982
• Diabetes Mellitus and Its Degenerative Complications: A Prospective Study of 4,400 Patients Observed Between 1947 and 1973
  Diabetes Care, 1978
• Hyperglycemia, Polyol Metabolism, and Complications of Diabetes Mellitus
  Annual Review of Medicine, 1975